SEARCH

SEARCH BY CITATION

References

  • Aydogan, T., Kanbay, M., Alici, O. & Kosar, A. (2006) Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets, 17, 328331.
  • Ballmaier, M. & Germeshausen, M. (2009) Advances in the understanding of congenital amegakaryocytic thrombocytopenia. British Journal of Haematology, 146, 316.
  • Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N & Green, A.R.; Cancer Genome Project (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 10541061.
  • Beer, P.A., Campbell, P.J., Scott, L.M., Bench, A.J., Erber, W.N., Bareford, D., Wilkins, B.S., Reilly, J.T., Hasselbalch, H.C., Bowman, R., Wheatley, K., Buck, G., Harrison, C.N. & Green, A.R. (2008) MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort. Blood, 112, 141149.
  • Bellanné-Chantelot, C., Chaumarel, I., Labopin, M, Bellanger, F., Barbu, V., De Toma, C., Delhommeau, F., Casadevall, N., Vainchenker, W., Thomas, G. & Najman, A. (2006) Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood, 108, 346352.
  • Carver-Moore, K., Broxmeyer, H.E., Luoh, S.M., Cooper, S., Peng, J., Burstein, S.A., Moore, M.W. & de Sauvage, F.J. (1996) Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood, 88, 803808.
  • Cazzola, M. (2008) Molecular basis of thrombocytosis. Haematologica, 93, 646648.
  • Cazzola, M & Skoda, R.C. (2000) Translational pathophysiology: a novel molecular mechanism of human disease. Blood, 95, 32803288.
  • Chaligné, R., Tonetti, C., Besancenot, R., Roy, L., Marty, C., Mossuz, P., Kiladjian, J.J., Socié, G., Bordessoule, D., Le Bousse-Kerdilès, M.C., Vainchenker, W. & Giraudier, S. (2008) New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition. Leukemia, 22, 15571566.
  • Cohen, N., Almoznino-Sarafian, D., Weissgarten, J., Alon, I., Zaidenstein, R., Dishi, V., Rahimi-Levene, N., Fried, K., Modai, D. & Golik, A. (1997) Benign familial microcytic thrombocytosis with autosomal dominant transmission. Clinical Genetics, 52, 4750.
  • Dame, C & Sutor, A.H. (2005) Primary and secondary thrombocytosis in childhood. British Journal of Haematology, 129, 165177.
  • Deutsch, V.R. & Torner, A. (2006) Megakaryocyte development and platelet production. British Journal of Haematology, 134, 453466.
  • Ding, J., Komatsu, H., Wakita, A., Kato-Uranishi, M., Ito, M., Satoh, A., Tsuboi, K., Nitta, M., Miyazaki, H., Iida, S. & Ueda, R. (2004) Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood, 103, 41984200.
  • Ding, J., Komatsu, H., Iida, S., Yano, H., Kusumoto, S., Inagaki, A., Mori, F., Ri, M., Ito, A., Wakita, A., Ishida, T., Nitta, M. & Ueda, R. (2009) The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarity. Blood, 114, 33253328.
  • Dror, Y. & Blanchette, V.S. (1999) Essential thrombocythaemia in children. British Journal Haematology, 107, 691698.
  • El-Harith, el-H.A., Roesl, C., Ballmaier, M., Germeshausen, M., Frye-Boukhriss, H., von Neuhoff, N., Becker, C., Nürnberg, G., Nürnberg, P., Ahmed, M.A., Hübener, J., Schmidtke, J., Welte, K. & Stuhrmann, M. (2009) Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene. British Journal of Haematology, 144, 185194.
  • Eyster, M. E., Saletans, L., Rabellino, E.M., Kaeanas, A., McDonald, T.P., Locke, L.R. & Luderer, A.J. (1986) Familial essential thrombocythemia. American Journal of Medicine, 80, 497502.
  • Fernandez-Robles, E., Vermylen, C., Martiat, P., Ninane, J. & Cornu, G. (1990) Familial essential thrombocythemia. Pediatric Hematology and Oncology, 7, 373376.
  • Finazzi, G. & Barbui, T. (2008) Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. Leukemia, 22, 14941502.
  • Geddis, A.E. (2010) Megakaryopoiesis. Seminars in Hematology, 47, 212219.
  • Ghilardi, N. & Skoda, R.C. (1999) A single-base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocytosis through a mechanism of more efficient translation of TPO mRNA. Blood, 94, 14801482.
  • Ghilardi, N., Wiestner, A. & Skoda, R.C. (1998) Thrombopoietin production is inhibited by a translational mechanism. Blood, 92, 40234030.
  • Ghilardi, N., Wiestner, A., Kikuchi, M., Oshaka, A. & Skoda, R.C. (1999) Hereditary thrombocythemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene. British Journal of Haematology, 107, 310316.
  • Graziano, C., Carone, S., Panza, E., Marino, F., Magini, P., Romeo, G., Pession, A. & Seri, M. (2009) Association of hereditary thrombocythemia and distal limb defects with a thrombopoietin gene mutation. Blood, 114, 16551657.
  • Griesshammer, M., Bangerter, M., Sauer, T., Wennauer, R., Bergmann, L. & Heimpel, H. (1999) Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. Journal of Internal Medicine, 245, 295300.
  • Griesshammer, M., Kubanek, B., Beneke, H., Heimpel, H., Bangerter, M., Bergmann, L. & Schrezenmeier, H. (2000) Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythaemia. Leukaemia & Lymphoma, 36, 533538.
  • Gurney, A.L., Carver-Moore, K., de Sauvage, F.J. & Moore, M.W. (1994) Thrombocytopenia in c-mpl-deficient mice. Science, 265, 14451447.
  • Higgs, J.R., Sadek, I., Neumann, P.E., Ing, V.W., Renault, N.K., Berman, J.N. & Greer, W. (2008) Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations. Leukemia, 22, 15511556.
  • James, C., Ugo, V., Le Couedic, J.P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., Villeval, J.L., Constantinescu, S.N., Casadevall, N. & Vainchenker, W. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 11441148.
  • Jones, A.V., Chase, A., Silver, R.T., Oscier, D., Zoi, K., Wang, Y.L., Cario, H., Pahl, H.L., Collins, A., Reiter, A., Grand, F. & Cross, N.C. (2009) JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nature Genetics, 41, 446449.
  • Jorgensen, M.J., Raskind, W.H., Wolff, J.F., Bachrach, H.R. & Kaushansky, K. (1998) Familial thrombocytosis associated with overproduction of thrombopoietin due to a novel splice donor site mutation. Blood (ASH Meeting Abstracts), 92, 205. Abstract # 834.
  • Kaser, A., Brandacher, G., Steurer, W., Kaser, S., Offner, F.A., Zoller, H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., Atkins, M.B., Mier, J.W. & Tilg, H. (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood, 98, 27202725.
  • Kaushansky, K. (2005) The molecular mechanisms that control thrombopoiesis. Journal of Clinical Investigation, 115, 33393347.
  • Kaushansky, K. (2009) Molecular mechanisms of thrombopoietin signalling. Journal of Thrombosis and Haemostasis, 7(Suppl 1), 235238.
  • Kaushansky, K., Lok, S., Holly, R.D., Broudy, V.C., Lin, N., Bailey, M.C., Forstrom, M.C., Buddle, M. M., Oort, P.J., Hagen, F. S., Roth, G. J., Papayannopoulou, T. & Foster, D. C. (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature, 369, 568571.
  • Kikuchi, M., Tayama, T., Hayakawa, H., Takahashi, I., Hoshino, H. & Ohsaka, A. (1995) Familial thrombocytosis. British Journal of Haematology, 89, 900902.
  • Kondo, T., Okabe, M., Sanada, M., Kurosawa, M., Suzuki, S., Kobayashi, M., Hosokawa, M. & Asaka, M. (1998) Familial essential thrombocythemia associated with one base deletion in the 5′-untranslated region of the thrombopoietin gene. Blood, 92, 10911096.
  • Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M. & Skoda, R.C. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, 352, 17791790.
  • Kuter, D.J. (2007) New thrombopoietic growth factors. Blood, 109, 46074616.
  • Kuter, D.J. & Rosenberg, R.D. (1995) The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood, 85, 27202730.
  • Kuter, D.J., Beeler, D.L. & Rosenberg, R.D. (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proceedings of the National Academy of Sciences of the United States of America, 91, 1110411108.
  • Landgren, O., Goldin, L.R, Kristinsson, S.Y, Helgadottir, E.A., Samuelsson, J. & Björkholm, M. (2008) Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood, 112, 219921204.
  • Levine, R.L., Wadleigh, M., Cools, J., Ebert, B.L., Wernig, G., Huntly, B.J., Boggon, T.J., Wlodarska, I., Clark, J.J., Moore, S., Adelsperger, J., Koo, S., Lee, J.C., Gabriel, S., Mercher, T., D’Andrea, A., Fröhling, S., Döhner, K., Marynen, P., Vandenberghe, P., Mesa, R.A., Tefferi, A., Griffin, J.D., Eck, M.J., Sellers, W.R., Meyerson, M., Golub, T.R., Lee, S.J. & Gilliland, D.G. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387397.
  • Liu, K., Kralovics, R., Rudzki, Z., Grabowska, B., Buser, A.S, Olcaydu, D., Gisslinger, H., Tiedt, R., Frank, P., Okoñ, K., van der Maas, A.P. & Skoda, R.C. (2008) A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica, 93, 706714.
  • Liu, K., Martini, M., Rocca, B, Amos, C.I., Teofili, L., Giona, F., Ding, J., Komatsu, H., Larocca, L.M. & Skoda, R.C. (2009) Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia. Haematologica, 94, 13681374.
  • Marty, C., Chaligné, R., Lacout, C., Constantinescu, S.N., Vainchenker, W. & Villeval, J.L. (2009) Ligand-independent thrombopoietin mutant receptor requires cell surface localization for endogenous activity. The Journal of Biological Chemistry, 284, 1178111791.
  • McIntosh, B. & Kaushansky, K. (2008) Marrow stromal production of thrombopoietin is regulated by transcriptional mechanisms in response to platelet products. Experimental Hematology, 36, 799806.
  • Moliterno, A. R., Hankins, W. D. & Spivak, J. L. (1998) Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New England Journal of Medicine, 338, 572580.
  • Moliterno, A.R., Williams, D.M, Gutierrez-Alamillo, L.I., Salvatori, R., Ingersoll, R.G. & Spivak, J.L. (2004) Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis. Proceedings of the National Academy of Sciences of the United States of America, 101, 1144411447.
  • Oh, S.T., Simonds, E.F., Jones, C., Hale, M.B., Goltsev, Y., Gibbs, Jr, K.D., Merker, J.D., Zehnder, J.L., Nolan, G.P. & Gotlib, J. (2010) Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood, 116, 988992.
  • Olcaydu, D., Harutyunyan, A., Jäger, R., Berg, T., Gisslinger, B., Pabinger, I., Gisslinger, H. & Kralovics, R. (2009) A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nature Genetics, 41, 450454.
  • Onishi, M., Mui, A.L., Morikawa, Y., Cho, L., Kinoshita, S., Nolan, G.P., Gorman, D.M., Miyajima, A. & Kitamura, T. (1996) Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood, 88, 13991406.
  • Pardanani, A.D., Levine, R.L., Lasho, T., Pikman, Y., Mesa, R.A., Wadleigh, M., Steensma, D.P., Elliott, M.A., Wolanskyj, A.P., Hogan, W.J., McClure, R.F., Litzow, M.R., Gilliland, D.G. & Tefferi, A. (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood, 108, 34723476.
  • Pecquet, C., Staerk, J., Chaligné, R., Goss, V., Lee, K.A., Zhang, X., Rush, J., Van Hees, J., Poirel, H.A., Scheiff, J.M., Vainchenker, W., Giraudier, S., Polakiewicz, R.D. & Constantinescu, S.N. (2010) Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor. Blood, 115, 10371048.
  • Percy, M.J. & Rumi, E. (2009) Genetic origins and clinical phenotype of familial and acquired erythrocytosis and thrombocytosis. American Journal of Hematology, 84, 4654.
  • Pikman, Y., Lee, B.H., Mercher, T., McDowell, E., Ebert, B.L., Gozo, M., Cuker, A., Wernig, G., Moore, S., Galinsky, I., DeAngelo, D.J., Clark, J.J., Lee, S.J., Golub, T.R., Wadleigh, M., Gilliland, D.G. & Levine, R.L. (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Medicine, 3, e270.
  • Qian, S., Fu, F., Li, W., Chen, Q. & deSauvage, F.J. (1998) Primary role of the liver in thrombopoietin production shown by tissue-specific knockout. Blood, 92, 21892191.
  • Robins, E.B. & Niazi, M. (2008) Essential thrombocythemia in a child with elevated thrombopoietin concentrations and skeletal anomalies. Pediatric Blood & Cancer, 50, 859861.
  • Rumi, E. (2008) Familial chronic myeloproliferative disorders: the state of the art. Hematological Oncology, 26, 131138.
  • Sabath, D.F., Kaushansky, K. & Broudy, V.C. (1999) Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding. Blood, 94, 365367.
  • Saur, S.J., Sangkhae, V., Geddis, A.E., Kaushansky, K. & Hitchcock, I.S. (2010) Ubiquitination and degradation of the thrombopoietin receptor c-Mpl. Blood, 115, 12541263.
  • de Sauvage, F.J., Hass, P.E., Spencer, S.D., Malloy, B.E., Gurney, A.L., Spencer, S.A., Darbonne, W.C., Henzel, W.J., Wong, S.C., Kuang, W.J., Oles, K.J., Hultgren, B., Solberg, L.A., Goeddel, D.V. & Eaton, D.L. (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature, 369, 533538.
  • Schafer, A.I. (2001) Thrombocytosis and thrombocythemia. Blood Reviews, 15, 159166.
  • Schafer, A.I. (2004) Thrombocytosis. New England Journal of Medicine, 350, 12111219.
  • Schlemper, R.J., van der Maas, A.P.C. & Eikenboom, J.C.J. (1994) Familial essential thrombocythemia: clinical characteristics of 11 cases in one family. Annals of Hematology, 68, 153158.
  • Scott, L.M., Tong, W., Levine, R.L., Scott, M.A., Beer, P.A., Stratton, M.R., Futreal, P.A., Erber, W.N., McMullin, M.F., Harrison, C.N., Warren, A.J., Gilliland, D.G., Lodish, H.F. & Green, A.R. (2007) JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. New England Journal of Medicine, 356, 459468.
  • Skoda, R.C. (2009) Thrombocytosis. Hematology/the Education Program of the American Society of Hematology, 159167.
  • Skoda, R. & Prchal, J.T. (2005) Lesson from familial myeloproliferative disorders. Seminars in Hematology, 42, 266273.
  • Slee, P.H., van Everdingen, J.J., Geraedts, J.P., te Velde, J. & den Ottolander, G.J. (1981) Familial myeloproliferative disease Hematological and cytogenetic studies. Acta Medica Scandinavica, 210, 321327.
  • Sohma, Y., Akahori, H., Seki, N., Hori, T., Ogami, K., Kato, T., Shimada, Y., Kawamura, K. & Miyazaki, H. (1994) Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Letters, 353, 5761.
  • Souyri, M., Vigon, I., Penciolelli, J.F., Heard, J.M., Tambourin, P. & Wendling, F. (1990) A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell, 63, 11371147.
  • Staerk, J., Lacout, C., Sato, T., Smith, S.O., Vainchenker, W. & Constantinescu, S.N. (2006) An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor. Blood, 107, 18641871.
  • Stoffel, R., Wiestner, A. & Skoda, R.C. (1996) Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood, 87, 567573.
  • Sungaran, R., Markovic, B. & Chong, B.H. (1997) Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood, 89, 101107.
  • Sungaran, R., Chisholm, O.T, Markovic, B., Khachigian, L.M., Tanaka, Y. & Chong, B.H. (2000) The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells. Blood, 95, 30943101.
  • Tecuceanu, N., Dardik, R., Rabizadeh, E., Raanani, P. & Inbal, A. (2006) A family with hereditary thrombocythaemia and normal genes for thrombopoietin and c-Mpl. British Journal of Haematology, 135, 348351.
  • Tefferi, A., Hanson, C.A. & Inwards, D.J. (2005) How to interpret and pursue an abnormal complete blood cell count in adults. Mayo Clinic Proceedings, 80, 923936.
  • Teofili, L., Pierconti, F., Di Febo, A., Maggiano, N., Vianelli, N., Ascani, S., Rossi, E., Pileri, S., Leone, G., Larocca, L.M. & De Stefano, V. (2002) The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia. Blood, 100, 714717.
  • Teofili, L., Giona, F., Martini, M., Cenci, T., Guidi, F., Torti, L., Palumbo, G., Amendola, A., Foà, R. & Larocca, L.M. (2007a) Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. Journal of Clinical Oncology, 25, 10481053.
  • Teofili, L., Giona, F., Martini, M., Cenci, T., Guidi, F., Torti, L., Palumbo, G., Amendola, A., Leone, G., Foà, R. & Larocca, L.M. (2007b) The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia. Blood, 110, 33843386.
  • Teofili, L., Foà, R., Giona, F. & Larocca, L.M. (2008) Childhood polycythemia vera and essentialthrombocythemia: does their pathogenesis overlap with that of adult patients? Haematologica, 93, 169172.
  • Teofili, L., Giona, F., Torti, L., Cenci, T., Ricerca, B.M., Rumi, C., Nunes, V., Foà, R., Leone, G., Martini, M. & Larocca, L.M. (2010) Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis. Haematologica, 95, 6570.
  • Thiele, J., Kvasnicka, H.M., Facchetti, F., Franco, V., van der Walt, J. & Orazi, A. (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica, 90, 11281132.
  • Tiedt, R., Coers, J., Ziegler, S., Wiestner, A., Hao-Shen, H., Bornmann, C., Schenke, J., Karakhanova, S., de Sauvage, F.J., Jackson, C.W. & Skoda, R.C. (2009) Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Blood, 113, 17681777.
  • Tong, W. & Lodish, H.F. (2004) Lnk inhibits Tpo-mpl signalling and Tpo-mediated megakaryocytopoiesis. The Journal of Experimental Medicine, 200, 569580.
  • Vannucchi, A.M., Antonioli, E., Guglielmelli, P., Pancrazzi, A., Guerini, V., Barosi, G., Ruggeri, M., Specchia, G., Lo-Coco, F., Delaini, F., Villani, L., Finotto, S., Ammatuna, E., Alterini, R., Carrai, V., Capaccioli, G, Di Lollo, S., Liso, V., Rambaldi, A., Bosi, A. & Barbui, T. (2008) Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia. Blood, 112, 844847.
  • Vigon, I., Mornon, J.P., Cocault, L., Mitjavila, M.T., Tambourin, P., Gisselbrecht, S. & Souyri, M. (1992) Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proceedings of the National Academy of Sciences of the United States of America, 89, 56405644.
  • Wendling, F., Maraskovsky, E., Debili, N., Florindo, C., Teepe, M., Titeux, M., Methia, N., Breton-Gorius, J., Cosman, D. & Vainchenker, W. (1994) cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature, 369, 571574.
  • Wiestner, A., Schlemper, R..J, van der Maas, A.P. & Skoda, R.C. (1998) An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nature Genetics, 18, 4952.
  • Wiestner, A., Padosch, S.A., Ghilardi, N., Cesar, J.M., Odriozola, J., Shapiro, A. & Skoda, R.C. (2000) Hereditary thrombocythaemia is a genetically heterogeneous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemia. British Journal of Haematology, 110, 104109.
  • Williams, E.C. & Shahidi, N.T. (1991) Benign familial thrombocytosis. American Journal of Hematology, 37, 124125.
  • Zhao, R., Xing, S., Li, Z., Fu, X., Li, Q., Krantz, S.B. & Zhao, Z.J. (2005) Identification of an acquired JAK2 mutation in polycythemia vera. The Journal of Biological Chemistry, 280, 2278822792.